thalidomide has been researched along with bq 123 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ansiaux, R; Beghein, N; Cron, GO; Feron, O; Gallez, B; Martinive, P | 1 |
1 other study(ies) available for thalidomide and bq 123
Article | Year |
---|---|
19F NMR in vivo spectroscopy reflects the effectiveness of perfusion-enhancing vascular modifiers for improving gemcitabine chemotherapy.
Topics: Animals; Antimetabolites, Antineoplastic; Botulinum Toxins, Type A; Carcinoma, Hepatocellular; Deoxycytidine; Drug Synergism; Fluorine Radioisotopes; Gemcitabine; Magnetic Resonance Spectroscopy; Male; Mice; Neoplasms, Experimental; Peptides, Cyclic; Thalidomide | 2008 |